Geriatric Surge: How China’s Aging Population is Propelling the Laxatives Market to Record Growth
China is currently experiencing one of the most rapid demographic shifts in modern history, with its population structure increasingly weighted towards the elderly. This profound change is not merely a social or economic concern; it is directly reshaping the country’s pharmaceutical landscape, particularly within the digestive health segment. As individuals age, their susceptibility to chronic gastrointestinal issues, especially constipation, increases significantly.
This is due to natural physiological changes, including reduced gut motility and a higher likelihood of using medications that list constipation as a side effect. Consequently, the demand for both prescription and over-the-counter (OTC) laxative products has seen a corresponding and dramatic uptrend. This demographic tailwind is establishing a powerful, non-cyclical driver for sustained market expansion, making the segment particularly attractive to both domestic and international pharmaceutical firms looking to capitalize on the needs of the world’s largest elderly population.


